ClinicalTrials.Veeva

Menu

Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria

B

Bispebjerg Hospital

Status

Completed

Conditions

Erythropoietic Protoporphyria

Study type

Observational

Funder types

Other

Identifiers

NCT03682731
Erythropoietic protoporphyria

Details and patient eligibility

About

Background: Erythropoietic protoporphyria (EPP) is characterized by development of painful skin symptoms upon exposure to visible light dye to accumulation of the photoactive substance protoporphyrin IX (PpIX) in the skin.This study aimed to quantify the actual light exposure of patients with EPP during everyday life. The investigators further aimed to establish the associations between symptoms and light exposure, use of protective clothes, and erythrocyte PpIX concentration.

Enrollment

14 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with erythropoietic protoporphyria
  • Informed consent

Exclusion criteria

  • None

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems